QA: Aprea Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001781983_2023_Aprea_Therapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001781983, Aprea Therapeutics Inc

  xvar xval
0 AssetsCurrent 30,153,506
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,321
3 remainder_Assets 0
4 LiabilitiesCurrent 3,201,086
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 24,230,902
9 ResearchAndDevelopmentExpense 14,014,048
10 remainder_Expenses 76,020,184
11 remainder_Revenues 0
12 remainder_NetIncome 555,784
13 remainder_ComprehensiveNetIncome -290,720
  yvar yval
0 Assets 30,155,827
1 Liabilities 3,201,086
2 Expenses 114,265,134
3 Revenues 0
4 StockholdersEquity 26,954,741
5 NetIncome -113,709,350
6 ComprehensiveNetIncome -113,854,710
7 BaseVar 74,234,276
8 EconomicCapitalRatiobeforeLimitedLiability -3.30
9 EconomicCapitalRatio 0.589

Edgar->Model Mapping

Feature Distribution

Change over Time